SCHEMBL19632250

SCHEMBL19632250

CCN(C)CCN(CC(=O)O)C(C)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
TDP1 Q9NUW8 2/20 0.36
EYA2 O00167 1/20 0.36
APP P05067 1/20 0.36
ACE P12821 1/20 0.36
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
CHRM2 P08172 1/20 0.34
ADRA2A P08913 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
DRD1 P21728 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
CYP2C19 P33261 1/20 0.34
ADRA1A P35348 1/20 0.34
DRD3 P35462 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15224079 0.83 TDP1 (0.39) KDM5AKDM4CTDP1EYA2APP
SCHEMBL15223823 0.82 LMNA (0.37) KDM5AKDM4CTDP1LMNACHRM2
SCHEMBL30241145 0.80 CA12 (0.44) TDP1EYA2APPACEKDM4E
SCHEMBL3714284 0.80 LMNA (0.39) TDP1EYA2APPACEKDM4E
SCHEMBL15223882 0.79 KDM5A (0.47) KDM5AKDM4CTDP1APPALOX15
SCHEMBL19389414 0.78 TDP1 (0.64) KDM5AKDM4CTDP1EYA2APP
SCHEMBL19400586 0.78 CA12 (0.43) KDM5AKDM4CLMNACHRM2KDM5B
SCHEMBL12417263 0.77 TDP1 (0.54) KDM5AKDM4CTDP1EYA2APP
SCHEMBL15498529 0.77 TDP1 (0.65) KDM5AKDM4CTDP1EYA2APP
SCHEMBL28085023 0.77 CA12 (0.48) TDP1APPALOX15TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170333567-A1 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers SYNTARGA BV (NL) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333567-A1 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers PCNA, DCLRE1A, CDC5L KDM5A 189/4885KDM4C 876/4885TDP1 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.